These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2559537)

  • 1. Cross-neutralizing and subclass characteristics of antibody from horses with equine infectious anemia virus.
    O'Rourke KI; Perryman LE; McGuire TC
    Vet Immunol Immunopathol; 1989 Nov; 23(1-2):41-9. PubMed ID: 2559537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection.
    Rwambo PM; Issel CJ; Adams WV; Hussain KA; Miller M; Montelaro RC
    Arch Virol; 1990; 111(3-4):199-212. PubMed ID: 2162160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus.
    Hammond SA; Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Sep; 262(2):416-30. PubMed ID: 10502520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic T lymphocytes and neutralizing antibody in the control of equine infectious anemia virus.
    McGuire TC; Fraser DG; Mealey RH
    Viral Immunol; 2002; 15(4):521-31. PubMed ID: 12513924
    [No Abstract]   [Full Text] [Related]  

  • 5. Control of equine infectious anemia virus is not dependent on ADCC mediating antibodies.
    Tschetter JR; Byrne KM; Perryman LE; McGuire TC
    Virology; 1997 Apr; 230(2):275-80. PubMed ID: 9143283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies.
    Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; Montelaro RC
    J Virol; 1987 Oct; 61(10):2956-61. PubMed ID: 2442410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T lymphocytes in protection against equine infectious anemia virus.
    McGuire TC; Fraser DG; Mealey RH
    Anim Health Res Rev; 2004 Dec; 5(2):271-6. PubMed ID: 15984338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of a rare neutralization-resistant variant following passive transfer of convalescent immune plasma in equine infectious anemia virus-challenged SCID horses.
    Taylor SD; Leib SR; Carpenter S; Mealey RH
    J Virol; 2010 Jul; 84(13):6536-48. PubMed ID: 20392850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of an equine infectious anemia virus Env-pseudotyped reporter virus.
    Tallmadge RL; Brindley MA; Salmans J; Mealey RH; Maury W; Carpenter S
    Clin Vaccine Immunol; 2008 Jul; 15(7):1138-40. PubMed ID: 18448619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of serum antibodies to equine infectious anemia virus reverse transcriptase.
    DeVico AL; Issel CJ; Le Grice SF; Payne SL; Montelaro RC; Sarngadharan MG
    AIDS Res Hum Retroviruses; 1993 Jan; 9(1):7-11. PubMed ID: 7678974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of equine infectious anemia virus escape from neutralizing antibody responses define epitope specificity.
    Sponseller BA; Clark SK; Friedrich RA
    Viral Immunol; 2012 Aug; 25(4):324-8. PubMed ID: 22746986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody escape kinetics of equine infectious anemia virus infection of horses.
    Schwartz EJ; Nanda S; Mealey RH
    J Virol; 2015 Jul; 89(13):6945-51. PubMed ID: 25878104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern.
    Lin YZ; Shen RX; Zhu ZY; Deng XL; Cao XZ; Wang XF; Ma J; Jiang CG; Zhao LP; Lv XL; Shao YM; Zhou JH
    Antiviral Res; 2011 Nov; 92(2):292-304. PubMed ID: 21893100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of broadly neutralizing immunoglobulin against homologous and heterologous equine infectious anemia virus infection in horses with severe combined immunodeficiency.
    Taylor SD; Leib SR; Wu W; Nelson R; Carpenter S; Mealey RH
    J Virol; 2011 Jul; 85(13):6814-8. PubMed ID: 21543497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication.
    Craigo JK; Leroux C; Howe L; Steckbeck JD; Cook SJ; Issel CJ; Montelaro RC
    J Gen Virol; 2002 Jun; 83(Pt 6):1353-1359. PubMed ID: 12029150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybridoma cell lines secreting monoclonal antibodies against equine infectious anemia virus.
    Horenstein AL; Glait HM; Koss A
    J Virol Methods; 1987 Feb; 15(3):177-85. PubMed ID: 2435751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.
    Howe L; Leroux C; Issel CJ; Montelaro RC
    J Virol; 2002 Nov; 76(21):10588-97. PubMed ID: 12368301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemagglutination-inhibition tests with different strains of equine infectious anemia virus.
    Sentsui H; Kono Y
    Am J Vet Res; 1981 Nov; 42(11):1949-52. PubMed ID: 6175255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of lentiviral infection in vivo in the absence of adaptive immune responses.
    Schwartz EJ; Vaidya NK; Dorman KS; Carpenter S; Mealey RH
    Virology; 2018 Jan; 513():108-113. PubMed ID: 29055819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection.
    Perryman LE; O'Rourke KI; McGuire TC
    J Virol; 1988 Aug; 62(8):3073-6. PubMed ID: 2839723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.